Globus Medical Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Globus Medical ha aumentado sus ingresos a un ritmo medio anual de 6.1%, mientras que la industria Medical Equipment ha visto aumentar sus ingresos growing a 9.1% anualmente. Los ingresos han crecido growing a un ritmo medio anual de 10.4%. Globus Medical La rentabilidad de los fondos propios de la empresa es de 3.8% y sus márgenes netos son de 12.9%.
Información clave
4.9%
Tasa de crecimiento de los beneficios
3.8%
Tasa de crecimiento del BPA
Crecimiento de la industria Medical Equipment | 8.9% |
Tasa de crecimiento de los ingresos | 12.6% |
Rentabilidad financiera | 3.1% |
Margen neto | 7.8% |
Próxima actualización de resultados | 07 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued
Apr 08Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly
Mar 20Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock
Feb 27Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?
Feb 09Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings
Jan 17Globus Medical: Merger Overhang Lingering
Nov 27Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?
Nov 14Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?
Oct 27Globus Medical: Almost Having My Back
Sep 13Globus Medical: Slightly Too Pricey Right Now
Aug 07Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy
Jul 18Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?
Jul 11Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching
Jun 18Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around
Apr 09What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?
Mar 22Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?
Feb 24Globus Medical Q4 2022 Earnings Preview
Feb 20Globus Medical: An Impressive Long-Term Revenue Growth Play
Jan 08Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
Dec 22Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends
Dec 01Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line
Nov 08A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)
Oct 15Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact
Sep 02Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around
Sep 02Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?
Aug 11Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective
Jun 05Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital
May 24Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
May 06An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued
Mar 14Globus Medical Continues To Flex Its Innovation Muscles To Drive Share Growth
Mar 01Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest
Feb 24Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture
Feb 08Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?
Jan 21Are Globus Medical, Inc. (NYSE:GMED) Investors Paying Above The Intrinsic Value?
Nov 28Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture
Nov 10At US$76.32, Is Globus Medical, Inc. (NYSE:GMED) Worth Looking At Closely?
Oct 19Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Globus Medical. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Dec 23 | 1,568 | 123 | 643 | 124 |
30 Sep 23 | 1,226 | 158 | 517 | 91 |
30 Jun 23 | 1,097 | 204 | 467 | 81 |
31 Mar 23 | 1,069 | 201 | 454 | 77 |
31 Dec 22 | 1,023 | 190 | 432 | 73 |
30 Sep 22 | 998 | 155 | 421 | 105 |
30 Jun 22 | 974 | 155 | 410 | 102 |
31 Mar 22 | 961 | 142 | 411 | 100 |
31 Dec 21 | 958 | 149 | 408 | 97 |
30 Sep 21 | 942 | 187 | 394 | 62 |
30 Jun 21 | 928 | 184 | 386 | 60 |
31 Mar 21 | 826 | 122 | 359 | 84 |
31 Dec 20 | 789 | 102 | 355 | 85 |
30 Sep 20 | 767 | 95 | 355 | 85 |
30 Jun 20 | 747 | 89 | 354 | 85 |
31 Mar 20 | 793 | 148 | 363 | 61 |
31 Dec 19 | 785 | 155 | 355 | 60 |
30 Sep 19 | 770 | 146 | 346 | 58 |
30 Jun 19 | 743 | 143 | 333 | 59 |
31 Mar 19 | 722 | 150 | 322 | 57 |
31 Dec 18 | 713 | 156 | 312 | 55 |
30 Sep 18 | 693 | 144 | 300 | 53 |
30 Jun 18 | 676 | 134 | 289 | 49 |
31 Mar 18 | 655 | 118 | 276 | 46 |
31 Dec 17 | 636 | 107 | 267 | 44 |
30 Sep 17 | 612 | 107 | 256 | 42 |
30 Jun 17 | 595 | 108 | 247 | 41 |
31 Mar 17 | 581 | 105 | 235 | 41 |
31 Dec 16 | 564 | 104 | 222 | 41 |
30 Sep 16 | 553 | 118 | 214 | 41 |
30 Jun 16 | 554 | 118 | 212 | 40 |
31 Mar 16 | 548 | 116 | 212 | 38 |
31 Dec 15 | 537 | 113 | 210 | 36 |
30 Sep 15 | 518 | 103 | 205 | 35 |
30 Jun 15 | 499 | 99 | 200 | 34 |
31 Mar 15 | 481 | 96 | 193 | 33 |
31 Dec 14 | 467 | 92 | 189 | 31 |
30 Sep 14 | 454 | 86 | 186 | 30 |
30 Jun 14 | 443 | 83 | 184 | 28 |
31 Mar 14 | 436 | 70 | 184 | 27 |
31 Dec 13 | 427 | 69 | 183 | 27 |
30 Sep 13 | 420 | 68 | 181 | 28 |
30 Jun 13 | 407 | 65 | 178 | 28 |
Ingresos de calidad: GMED tiene un gran one-off loss de $81.4M impacto en sus últimos 12 meses de resultados financieros a 30th September, 2023.
Margen de beneficios creciente: GMEDLos actuales márgenes de beneficio netos de (12.9%) son inferiores a los del año pasado (15.5%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: GMEDLos beneficios de la empresa han crecido un 6.1% al año en los últimos 5 años.
Acelerando crecimiento: GMED's ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: GMED tuvo un crecimiento negativo de los beneficios (-35.4%) durante el año pasado, lo que dificulta la comparación con la media del sector Medical Equipment (6.7%).
Rentabilidad financiera
Alta ROE: El Retorno sobre el capital de GMED (3.8%) se considera bajo.